Cancer cell's 'self eating' tactic may be its weakness

Cancer cell's 'self eating' tactic may be its weakness
Evidence of activity involving the NIX protein (brown staining) is seen in common precursor lesions (PanIN) for pancreatic cancer. NIX activity escalates in full pancreatic ductal adenocarcinoma (PDAC), the most common of pancreas cancers. NIX is directly responsible for triggering mitophagy, or "self eating" of mitochondria. Credit: Tuveson lab/CSHL

Cancer cells use a bizarre strategy to reproduce in a tumor's low-energy environment; they mutilate their own mitochondria! Researchers at Cold Spring Harbor Laboratory (CSHL) also know how this occurs, offering a promising new target for pancreatic cancer therapies.

Why would a cell want to destroy its own functioning mitochondria? "It may seem pretty counterintuitive," admits M.D.-Ph.D. student Brinda Alagesan, a member of Dr. David Tuveson's lab at CSHL.

According to Alagesan, the easiest way to think about why may do this is to think of the mitochondria as a powerplant. "The mitochondria is the powerhouse of the cell," she recites, recalling the common grade school lesson. And just like a traditional powerplant, the mitochondria create their own pollution.

"These harmful byproducts, or pollutants, are called , or ROS," Alagesan adds. "A lot of it can be damaging to cells. We believe that [by eating their own mitochondria] the pancreatic cancer cells are reducing the production of these damaging ROS while still making enough energy to proliferate."

This is still a hypothesis but it could explain why pancreatic cancer cells become prone to mitophagy, a form of autophagy or 'self eating' of their mitochondria.

In the journal Cancer Discovery, Alagesan and co-lead author Dr. Timothy Humpton describe what happens when a protein called KRAS becomes active in the uniquely nutrient-depleted environment of a pancreas tumor. KRAS starts a "signaling cascade" which results in the cell eating its own mitochondria and the diversion of glucose and glutamine away from the remaining . These diverted nutrients are used to support .

"Ideally, we would want to inhibit the cancer promoting KRAS protein directly, but unfortunately so far no one has been able to do that in a clinically relevant way," Alagesan explains.

Instead of stopping KRAS directly, the Tuveson team traced the cascade of protein signals that follows KRAS activation. They found one pathway which leads to an increase in the protein NIX. NIX is directly responsible for triggering that mitophagy stage which appears to be so crucial for cancer cell proliferation.

"Results in mice are showing us that, by inhibiting the NIX pathway, we might prevent cancer cells from using energy the way they need to in order to proliferate," Alagesan says.

The Tuveson team is now turning its attention to disrupting this same NIX pathway in human pancreatic cancer , and applying this to the design of clinical trials.


Explore further

New potential therapeutic target for pancreatic cancer discovered

Journal information: Cancer Discovery

Citation: Cancer cell's 'self eating' tactic may be its weakness (2019, July 1) retrieved 20 August 2019 from https://medicalxpress.com/news/2019-07-cancer-cell-tactic-weakness.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Jul 01, 2019
Thanks for useful information.
I'm a writer and I think a lot of peaple have to read your article. Do you want to write article for different audience? Write to editor http://getessayeditor.com/

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more